The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Open accessAbstract
BACKGROUND: We used modeling techniques to assess the relative and absolute contributions of screening mammography and adjuvant treatment to the reduction in breast-cancer mortality in the United States from 1975 to 2000. METHODS: A consortium of investigators developed seven independent statistical models of breast-cancer incidence and mortality. All seven groups used the same sources to obtain data on the use of screening mammography, adjuvant treatment, and benefits of treatment with respect to the rate of death from breast cancer. RESULTS: The proportion of the total reduction in the rate of death from breast cancer attributed to screening varied in the seven models from 28 to 65 percent (median, 46 percent), with adjuvant treatment contributing the rest. The variability across models in the absolute contribution of screening was larger than it was for treatment, reflecting the greater uncertainty associated with estimating the benefit of screening. CONCLUSIONS: Seven statistical models showed that both screening mammography and treatment have helped reduce the rate of death from breast cancer in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Wand, M. P., & Jones, M. C. (1995) · Springer eBooks · doi:10.1007/978-1-4899-4493-1 · Cited by 2,663
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
Humphrey, L. L., Helfand, M., Chan, B. K. S., & Woolf, S. H. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00012 · Cited by 1,137
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P., Foster, R. S., Hendrick, E., Eyre, H. J., & Sener, S. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.3.141 · Cited by 770
Swan, J., Breen, N., Coates, R. J., Rimer, B. K., & Lee, N. C. (2003) · Cancer · doi:10.1002/cncr.11208 · Cited by 767
Cochrane review on screening for breast cancer with mammography
Olsen, O., & Gøtzsche, P. C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06449-2 · Cited by 710
Miller, A. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1490 · Cited by 512
Breen, N., Wagener, D. K., Brown, M. L., Davis, W. W., & Ballard-Barbash, R. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1704 · Cited by 502
Cited by
Items 101–134 of 134
Breast cancer screening in developing countries
da Costa Vieira, R. A., Biller, G., Uemura, G., Ruiz, C. A., & Curado, M. P. (2017) · Clinics · doi:10.6061/clinics/2017(04)09 · Cited by 293
Analysis of Breast Cancer Mortality in the US—1975 to 2019
Caswell-Jin, J. L., Sun, L. P., Munoz, D., Lu, Y., Li, Y., Huang, H., Hampton, J. M., Song, J., Jayasekera, J., Schechter, C., et al. (2024) · JAMA · doi:10.1001/jama.2023.25881 · Cited by 284
Self-citationMandelblatt, J. S., Stout, N. K., Schechter, C. B., van den Broek, J. J., Miglioretti, D. L., Krapcho, M., Trentham-Dietz, A., Munoz, D., Lee, S. J., Berry, D. A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1536 · Cited by 281
Self-citationTumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Tang, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.024 · Cited by 276
The Global Breast Cancer Burden
Benson, J. R., & Jatoi, I. (2012) · Future Oncology · doi:10.2217/fon.12.61 · Cited by 274
Treatment of HER2-positive breast cancer
Figueroa-Magalhães, M. C., Jelovac, D., Connolly, R. M., & Wolff, A. C. (2014) · The Breast · doi:10.1016/j.breast.2013.11.011 · Cited by 273
The WISDOM Study: breaking the deadlock in the breast cancer screening debate
Esserman, L. J., the WISDOM Study and Athena Investigators, Anton-Culver, H., Borowsky, A., Brain, S., Cink, T., Crawford, B., Eklund, M., Esserman, L., Fenton, J., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0035-5 · Cited by 272
Applying What We Know to Accelerate Cancer Prevention
Colditz, G. A., Wolin, K. Y., & Gehlert, S. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003218 · Cited by 268
Mindfulness-Based Stress Reduction for Breast Cancer—A Systematic Review and Meta-Analysis
Cramer, H., Lauche, R., Paul, A., & Dobos, G. (2012) · Current Oncology · doi:10.3747/co.19.1016 · Cited by 256
Benson, J. R., Jatoi, I., Keisch, M., Esteva, F. J., Makris, A., & Jordan, V. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60316-0 · Cited by 261
O’Keefe, E. B., Meltzer, J. P., & Bethea, T. N. (2015) · Frontiers in Public Health · doi:10.3389/fpubh.2015.00051 · Cited by 259
Long term side effects of adjuvant chemotherapy in patients with early breast cancer
Tao, J. J., Visvanathan, K., & Wolff, A. C. (2015) · The Breast · doi:10.1016/j.breast.2015.07.035 · Cited by 258
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
Dave, B., Mittal, V., Tan, N. M., & Chang, J. C. (2012) · Breast Cancer Research · doi:10.1186/bcr2938 · Cited by 257
Adherence to endocrine therapy for breast cancer
Chlebowski, R. T., & Geller, M. L. (2006) · Oncology · doi:10.1159/000100444 · Cited by 251
Screening for Pancreatic Cancer: Why, How, and Who?
Poruk, K. E., Firpo, M. A., Adler, D. G., & Mulvihill, S. J. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31825ffbfb · Cited by 249
Reported drop in mammography: Is this cause for concern?
Breen, N., A. Cronin, K., Meissner, H. I., Taplin, S. H., Tangka, F. K., Tiro, J. A., & McNeel, T. S. (2007) · Cancer · doi:10.1002/cncr.22723 · Cited by 198
Data resource profile: the Human Mortality Database (HMD)
Barbieri, M., Wilmoth, J. R., Shkolnikov, V. M., Glei, D., Jasilionis, D., Jdanov, D., Boe, C., Riffe, T., Grigoriev, P., & Winant, C. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv105 · Cited by 168
Cancer treatment cost in the United States: Has the burden shifted over time?
Tangka, F. K., Trogdon, J. G., Richardson, L. C., Howard, D., Sabatino, S. A., & Finkelstein, E. A. (2010) · Cancer · doi:10.1002/cncr.25150 · Cited by 156
Zhang, J., Xu, R., Wang, B., & Wang, J. (2016) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2016.02.012 · Cited by 130
Cluze, C., Rey, D., Huiart, L., BenDiane, M. K., Bouhnik, A. D., Berenger, C., Carrieri, M. P., & Giorgi, R. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr330 · Cited by 133
Yoga and meditation for menopausal symptoms in breast cancer survivors—a randomized controlled trial
Cramer, H., Rabsilber, S., Lauche, R., Kümmel, S., & Dobos, G. (2015) · Cancer · doi:10.1002/cncr.29330 · Cited by 131
Hypnosis in Breast Cancer Care: A Systematic Review of Randomized Controlled Trials
Cramer, H., Lauche, R., Paul, A., Langhorst, J., Kümmel, S., & Dobos, G. J. (2015) · Integrative Cancer Therapies · doi:10.1177/1534735414550035 · Cited by 111
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)
Saadatmand, S., Obdeijn, I., Rutgers, E. J., Oosterwijk, J. C., Tollenaar, R. A., Woldringh, G. H., Bergers, E., Verhoef, C., Heijnsdijk, E. A., Hooning, M. J., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29534 · Cited by 96
VANNI, G., TAZZIOLI, G., PELLICCIARO, M., MATERAZZO, M., PAOLO, O., CATTADORI, F., COMBI, F., PAPI, S., PISTOLESE, C. A., COTESTA, M., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14741 · Cited by 91
Font, R., Espinas, J. A., Gil-Gil, M., Barnadas, A., Ojeda, B., Tusquets, I., Segui, M. A., Margelí, M., Arcusa, A., Prat, A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.389 · Cited by 79
Di Meglio, A., Havas, J., Gbenou, A. S., Martin, E., El-Mouhebb, M., Pistilli, B., Menvielle, G., Dumas, A., Everhard, S., Martin, A.-L., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.00277 · Cited by 76
Guidelines for multi-model comparisons of the impact of infectious disease interventions
den Boon, S., Jit, M., Brisson, M., Medley, G., Beutels, P., White, R., Flasche, S., Hollingsworth, T. D., Garske, T., Pitzer, V. E., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1403-9 · Cited by 67
Chou, Y.-H., Chia-Rong Hsieh, V., Chen, X., Huang, T.-Y., & Shieh, S.-H. (2020) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2020.01.010 · Cited by 54
Dobos, G., Overhamm, T., Büssing, A., Ostermann, T., Langhorst, J., Kümmel, S., Paul, A., & Cramer, H. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2660-6 · Cited by 54
Viale, G., Licata, L., Sica, L., Zambelli, S., Zucchinelli, P., Rognone, A., Aldrighetti, D., Di Micco, R., Zuber, V., Pasetti, M., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0316 · Cited by 35
Coping Among Breast Cancer Survivors: A Confirmatory Factor Analysis of the Brief COPE
Rand, K. L., Cohee, A. A., Monahan, P. O., Wagner, L. I., Shanahan, M. L., & Champion, V. L. (2019) · Journal of Nursing Measurement · doi:10.1891/1061-3749.27.2.259 · Cited by 32
Accepting the existence of breast cancer overdiagnosis
Brawley, O. W. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2850 · Cited by 26
Christensen, E. W., Waid, M., Scott, J., Patel, B. K., Bello, J. A., & Rula, E. Y. (2023) · Radiology · doi:10.1148/radiol.221153 · Cited by 20
Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients
Vang, S. S., Dunn, A., Margolies, L. R., & Jandorf, L. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07189-3 · Cited by 14
Metadata
- Authors
- Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-27
- Volume
- 353
- Issue
- 17
- Pages
- 1784-1792
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2045216597
- Cited by
- 2,460
- References
- 19
- FWCI
- 38.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.